Open App →
Back to News Feed
PR Newswire November 16, 2026 positive

Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation

AI / LLM
<p>HealthQuest Capital leads financing to support Aliya commercial expansion, clinical evidence generation, pipeline advancement, and development of next-generation pulsed electric field ablation platforms REDWOOD CITY, Calif., Nov. 16, 2026 /PRNewswire/ -- Galvanize Therapeutics®, a...</p>
Read original article ↗

Related Articles

New high-speed train begins tests at THSRC depot

Taipei Times · November 17, 2026

Taiwan ranked for AI integration, enthusiasm

Taipei Times · November 17, 2026

Furloughed workers in Taiwan fall to 19-month low

Taipei Times · November 17, 2026